Chris Hitchcock
Development Team Leader @Pfizer
Signup · Get unlimited contacts
WORK HISTORY
Development Team Leader @Pfizer
EDUCATION
University of Wales, Cardiff
Ph.D.
ABOUT CHRIS HITCHCOCK
Twenty seven years’ experience in drug discovery and development as a discovery line head and executive team leader of global, multi-disciplinary teams of up to 100 staff in Pfizer Global R&D and Astellas Pharma Global Development working in Europe, the US and Japan. Leader of the teams responsible for discovering the life-saving, broad-spectrum antifungal agent, VFend (Voriconazole) and exploratory development of the anti-HIV agent, Selzentry (Maraviroc), with combined sales >$1Bn. Accomplished leader of Phase programs across a wide range of therapeutic areas (Anti-Infectives, Inflamation, Endocrine, Cardiovascular, Pain, Allergy & Respiratory, Oncology, Ophthalmology, Dermatology, Urology and Nephrology), regulatory filing and interactions (FDA, EMEA & PMDA), running large biotechnology and Pharma collaborations (e.g. Millennium, Virologic/Monogram, Janssen Biotech & FibroGen), therapeutic area strategy development and commercial product support. Driven business development initiatives aimed at maximising the return-on-investment of R&D assets (compounds, technologies & infrastructure) through value propositions and business plans that align with internal business units, as well as in-licensing/out-licensing assets and innovative business models for sharing risk and cost with external investors. Driven global initiatives to improve cost-effectiveness of managing Phase I/II candidate attrition, strategic alignment between Research, Development and Commercial Divisions and embed organisational learning. Chaired scientific advisory boards (academic, industrial & government) and presented at numerous international meetings on strategic and technical aspects of pharmaceutical R&D. Recognised as one of the Top 50 Research Leaders in Medical Treatment by Scientific American (2003-04) for the discovery and exploratory development of VFend and Selzentry. Selzentry was named ‘Best Pharmaceutical Agent’ at the Prix Galien USA 2008 awards.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.